Population
Patients with osteoarthritis (OA)
Design
Cross-sectional
Authors
Loading...
Alerts to interaction risks in OA polypharmacy; leaves open causal safety questions for prospective study.
There is an increasing use of opioids and COX-2 inhibitors among OA patients, highlighting the need to monitor for potential drug interactions and safety issues.
Wilson et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: